← Back to Search

Support Programs for Domestic Violence

N/A
Recruiting
Led By Caroline Piotrowski, PhD MPH
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* mothers self-reported experience of past intimate partner violence, English-speaking, with at least one school-aged child
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured 6-8 months post-intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at two programs designed to help Indigenous mothers and children affected by intimate partner violence in Canada.

Who is the study for?
This trial is for Indigenous mothers in Canada who speak English and have experienced intimate partner violence. They must have at least one child of school age to participate.
What is being tested?
The study is testing two programs: the Mother's Empowerment Program and the Kid's Club Program, both tailored for Indigenous families affected by domestic violence.
What are the potential side effects?
Since these interventions are social support programs rather than medical treatments, they may not have physical side effects but could bring emotional responses or changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured 6-8 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured 6-8 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Child Anxiety
Child Depression
Child trauma symptoms
+3 more
Secondary study objectives
Child resilience
Maternal resilience
Maternal self esteem
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Wait List ControlExperimental Treatment1 Intervention
Participants receive intervention after 12 week delay

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
620 Previous Clinical Trials
206,621 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,517,924 Total Patients Enrolled
Caroline Piotrowski, PhD MPHPrincipal InvestigatorUniversity of Manitoba
~95 spots leftby Dec 2025